{"nct_id":"NCT05253807","title":"Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2022-04-29","start_date_type":"ACTUAL","primary_completion_date":"2023-08-16","primary_completion_date_type":"ACTUAL","completion_date":"2023-08-16","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["INCY"]}